You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Cara Therapeutics Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Cara Therapeutics Company Info
News & Analysis
Here are seven steps to investing in the high-flying cannabis industry.
There's good news at long last for the beaten-down biotech stock.
The biotech gets an important nod from a top regulator.
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.
Maybe, if you're itching to speculate.
The company reported disappointing results from a phase 2 study.
The biotech stock is being added to an important small-cap index.
Both of these biotechs could have big catalysts on the way.
CARA earnings call for the period ending September 30, 2021.
CARA earnings call for the period ending June 30, 2021.
CARA earnings call for the period ending March 31, 2021.
CARA earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.